Neudle.com: monoclonal antibodies

Differential
(Click to cross reference)

abciximab

abdominal protrusion

abdominal reflex, absent

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acoustic neurinoma

acquired immunodeficiency syndrome

acute coronary syndrome

acute intermittant porphyria

advances in neurology

adverse drug reaction

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

amblyopia, toxic

AMPA receptor antibodies

amyloid

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid plaques

amyloidosis

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, work up

anasarca

anemia

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiography, cerebral

angiotensin-converting enzyme

ankle edema

ankylosing spondylitis

anti GQ1b IgG antibody

anti JC virus antibodies

anti MAG antibodies

anti Yo antibody

anti-amyloid therapy

anticardiolipin antibodies

anticoagulant, complications of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

antineutrophil cytoplasmic autoantibodies

antiphospholipid antibodies

anxiety

aortic wall, thickened

aortitis

aphasia

apolipoprotein E

apoliprotein E, plasma level

arachnoiditis

area postrema

area postrema syndrome

areflexia

arteritides

arteritis, temporal

arteritis, temporal, recurrent

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

B cell lymphocyte depletion

B cell lymphocytes

bacterial endocarditis, neurologic manifestations of

bacterial infection, CNS

basal ganglia, lesion of

basal ganglia, lesion, bilateral

basilar artery occlusion

basilar artery stenosis

behavioral disorder

behavioral disorder, acute

bone marrow transplantation

bone survey

bone survey, metastatic

border zone infarct

brachial plexus injury

brachial plexus neuropathy

bradykinesia

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

bulbar palsy, progressive

calcification, intracranial

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

camptocormia

cancer associated myopathy

cardiac surgery, neurologic complications with

cardiac transplantation

cardiotoxicity

carotid artery, enlarged external diameter

carpal tunnel syndrome

CAT scan, angiography

CAT scan, base of skull

CAT scan, chest

CAT scan, contrast enhanced

CAT scan, contrast enhanced, subepend.

CAT scan, dense artery sign

CAT scan, dense artery sign, disappearing

CAT scan, emission, abnormal

catatonia

cauda equina

cauda equina, enhancement

cauda equina, lesion of

CD4 counts

central nervous system, infection of

central retinal vein occlusion

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar infarction

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral cortex

cerebral edema

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, immunoglobulins of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, proteincytologic dissociation

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, awakening with

cerebrovascular accident, multiple

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, young adult

cerebrovascular disease

chairbound

chemotherapy, CNS treatment and complications with

chest pain

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

confusional state, acute

congenital malformation

congestive heart failure

contraindications

controversies in neurology

cop 1

corneal dystrophy

corpus callosum, lesion of

cost

cost effectiveness

cranial nerve palsies

cranial nerve palsies, recurrent

cranial neuropathy

cranial neuropathy, multiple

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

cytomegalovirus infection

dementia, rapidly progressive

dementia, reversible

dementia, treatment of

demyelinating disease

denervation of muscle

denervation potentials

dentate nuclei

dentate nuclei, lesion of

dermatomyositis

developmental milestones, loss of

differential diagnosis

difficulty climbing stairs

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

disorientation

distal muscle atrophy

distal muscle weakness

diurnal variation

dizziness

donanemab

DPPX, antibodies, encephalitis

dropped head syndrome

drug abuse

drug holiday

drug induced neurologic disorders

dyskinesia, buccal lingual facial

electrocardiogram, abnormal

electroencephalogram, abnormalities of

electromyogram

electron microscopy

electrophoretic pattern, serum

electrophoretic pattern, urine

embolism, vertebral-basilar artery

emotional lability

encephalitis

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, delayed

endocarditis

endocarditis, infectious

endocarditis, subacute bacterial

endocarditis, treatment of

eosinophilia

eosinophilic granulomatosis with polyangiitis

epidemiology of neurology

Epstein-Barr virus, negative

erythropoietin treatment

etanercept

evidence-based research

extralimbic encephalitis

extraocular muscle enlargement

extraocular muscle lesion

eye movement, painful

eye, pain in

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

facial weakness, bilateral

faciobrachial dystonic seizure

fibrinolytic agents, intra-arterial local infusion

fingolimod

Fisher's syndrome

fluorescein angiography

fungal infection, CNS

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granuloma, eosinophilic

granulomatosis with polyangiitis

granulomatous disease

granulomatous hypophysitis

Guillain Barre syndrome

Guillain Barre syndrome, differential diagnosis of

gynecomastia

hallucination

hallucination, olfactory

hallucination, visual

halo sign

headache

headache, children

headache, drug induced

headache, episodic

headache, preventive treatment

headache, prophylaxis

headache, recurrent

headache, severe

headache, treatment of

hemiplegia, progressive

hemoglobinuria

hemolysis

hemophagocytic lymphohistiocytosis

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemosiderosis, subarachnoid

heparin

heparinoid, low molecular weight

hepatic failure

hepatomegaly

hepatosplenomegaly

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex virus infection, immunosuppressed patient

herpes virus infection

herpes zoster

hiccoughs

highly active antiretroviral therapy

hip flexor weakness

hippocampus

histochemistry of muscle

HLA

hoarseness

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

hormone replacement

human immunodeficiency virus type 1

hydrocephalus

hypercalcemia

hyperekplexia

hypereosinophilic syndrome(HES)

hyperpigmentation of skin

hypersensitivity reaction

hypertension

hypertensive retinopathy

hypertrichosis

hypertrophic intracranial pachymeningitis

hyperviscosity

hyperviscosity syndrome

hypoglycorrhachia

hypogonadism

hyponatremia

hypophysitis, IgG4-related

hypopigmentation of skin

hypothalamus, lesion of

hypoxia

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

IgG4, serum

IgG4-related disease

imbalance

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunoelectrophoresis, serum

immunofluorescence

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

impotence

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

infusion-associated reaction

internal carotid artery

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracerebral hemorrhage, small

intracranial hypertension, benign

intrauterine

ipilimumab

iritis

iron, serum, elevated

Janus kinase inhibitors

JC virus

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

lacrimal gland enlargement

lactic dehydrogenase(LDH)

leg weakness, bilateral

leprosy

leucine rich glioma inactivated 1 antibodies

leukemia

leukemia, neurologic findings assoc.with

leukocytosis

leukoencephalopathy

leukoencephalopathy, toxic

leukopenia

levamisole

level of consciousness, decreased

lipoprotein receptor-related protein 4

listeria monocytogenes

liver function enzymes

lymphadenopathy, cervical

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphomatoid granulomatosis

lymphopenia

macroglobulinemia

masseter muscle wasting

medial rectus palsy

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

melanoma, malignant

melphalan

memory, defect of recent

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, chronic

meningitis, drug induced

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningitis, TB

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental status, abnormal

mercaptopurine

mesial temporal lobe

methotrexate

microhemorrhage, intracerebral

microscopic polyangiitis

microsporidia

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

middle cerebral artery, occlusion of

migraine

migraine, children

migraine, chronic

migraine, intractable

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

Mikulicz's syndrome

mild cognitive impairment

mimics

misdiagnosis

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

monoclonal gammopathy

monoclonal gammopathy of uncertain significance

mononeuritis multiplex

mononeuritis multiplex, causes of

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, lesion burden

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, nodular enhancement

MRI, optic nerve

MRI, orbit

MRI, punctate pattern

MRI, ring sign

MRI, ring sign, open

MRI, serial

MRI, skull bone changes

MRI, spinal cord

MRI, spinal cord, increased intramedullary cord signal

MRI, vessel wall

MRS

multifocal fibrosclerosis

multinucleated giant cell

multiple myeloma

multiple sclerosis

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muromonab-CD3

muscle atrophy, progressive

muscle biopsy

muscle biopsy, extraocular

muscle pain

muscle stiffness

muscle wasting, diffuse

muscle weakness

muscle weakness, proximal

muscle weakness, sudden onset of

MuSK antibodies

mutism

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, infantile and juvenile

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, recurrent

myeloma, osteosclerotic

myopathy, inflammatory

myopathy, necrotizing

myopathy, necrotizing, immune-mediated

myopathy, proximal

myopathy, steroid responsive

natalizumab antibodies

natalizumab, discontinuation

necrotizing vasculitis

negative

nemaline rod myopathy

nemaline rod myopathy, adult onset

neoplasm, metastatic

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-differential diagnosis

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

neoplastic angioendotheliosis

nerve biopsy

nerve conduction studies

nerve conduction studies, motor

neurexin-3 alpha antibodies

neuroendocrinology

neurofibromatosis 2

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multiple

neurologic signs

neurologic symptoms

neurolymphomatosis

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuropathy, asymptomatic

neuropathy, ataxic

neuropathy, chronic

neuropathy, cryoglobulinemic

neuropathy, demyelinating

neuropathy, diabetic

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, painful

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, systemic

neuroradiology, interventional

neurotoxic

nevus

new onset refractory status epilepticus

nonsteroidal anti-inflammatory drug

nortriptyline

numbness, extremity

ocrelizumab

ocular motility, disorders of

oculovestibular reflex

ofatumumab

old age, neurology of

ophelia syndrome

ophthalmoplegia

ophthalmoplegia, painful

ophthalmoplegia, total

opisthotonus

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic disc edema

optic nerve, enhancement

optic nerve, lesion of

optic neuritis

optic neuropathy

optic neuropathy, toxic

oral contraceptives

oral contraceptives, cerbrovascular disease and

orbit, biopsy

orbit, inflammation in

orbit, lesions of

orbit, pseudotumor of

orbital apex

organ transplantation

organomegaly

orthostatic hypotension

osteolytic lesion, causes of

overlap syndrome

pachymeningitis, cranial

paralysis, asymmetric

paraneoplastic cerebellar degeneration

paraparesis

paraproteinemia

parasitic infection

parasitic infection, CNS

paraspinal muscle

paraspinal muscle weakness

paresthesias

paresthesias, feet

paresthesias, hands

parotid gland swelling

paroxysmal nocturnal hemoglobinuria

pathology

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pembrolizumab

pentoxifylline

pericarditis

peripheral blood stem cell transplantation

personality change

pituitary stalk

pituitary stalk, enlarged

placebo

plasma cell dyscrasia

plasma cell myeloma, CNS involvement associated with

plasmacytoma

plasmapheresis

plasmapheresis, complications of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

pleural effusion

pneumonia

POEMS syndrome

polyclonal gammopathy

polycythemia, secondary

polymerase chain reaction

polymerase chain reaction, false negative

polymyalgia rheumatica

polymyositis

polyneuropathy

polyneuropathy, chronic idiopathic

polyneuropathy, chronic idiopathic, ataxic

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, chronic inflammatory demyelinating, variant form

polyneuropathy, chronic inflammatory demyelinating-pure motor syn

polyneuropathy, chronic inflammatory demyelinating-sens atax var

polyneuropathy, chronic inflammatory demyelinating-variant forms

polyneuropathy, chronic relapsing

polyneuropathy, subacute idiopathic demyelinating

polyneuropathy, uremic

polyradiculoneuropathy

pons, lesion of

pontine hemorrhage

positive sharp waves

post herpetic neuralgia

post transplant lymphoproliferative disease

posterior circulation stroke

posterior leukoencephalopathy syndrome

postoperative neurologic complications

postpartum

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

preclinical

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive spinal muscular atrophy

proprioception, abnormal

proptosis

proptosis, unilateral

psychiatric problems in neurologic disorders

pulmonary infiltrates

radiation therapy, CNS treatment and complications with

radiation therapy, total body

rapidly fatal neurologic illness

rapidly progressing neurologic illness

rash

ravulizumab

recanalization, arterial

recurrent

recurrent laryngeal nerve paralysis

regional enteritis

remote effect of cancer on the nervous system

remternetug

remyelination

renal failure

renal transplantation

reocclusion, cerebral artery

respiratory failure

retroperitoneal fibrosis

rheumatoid arthritis, neurologic complications of

rimegepant

risk factors

risk stratification

risk-benefit assessment

salivary gland enlargement

sedimentation rate, elevated

seizure

seizure, focal

seizure, intractable

seizure, psychomotor-temporal lobe

seizure, treatment of

sensory loss

sensory polyneuropathy

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

shared decision making

shoulder, pain in

sialadenitis

skin, biopsy

skin, lesions in neurologic disorders

skin, thickened

sleep pathology and physiology

small vessel vasculitis

soluble interlukin 2 receptor

somnolence

speech disorder

speech disorder, childhood

spinal cord

spinal cord, lesion of

splenic-vein thrombosis

splenomegaly

standing difficulty

status epilepticus

status epilepticus, intractable

stem cell transplantation

stent, basilar artery

stent, basilar artery, efficacy

stent, carotid artery, complications

steppage gait

steroid

steroid sparing therapy

steroid therapy, CNS treatment and complications with

stiff joints

stooped posture

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

strokelike episodes

subarachnoid hemorrhage

temporal artery, biopsy

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

thrombocytopenia

thrombocytosis

thrombotic thrombocytopenia purpura

tissue plasminogen activator, intravenous

tocilizumab

tongue, atrophy

tongue, fasciculations of

toxoplasmosis, acquired

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transcutaneous electrical nerve stimulation

transient ischemic attack

transluminal angioplasty, carotid artery

transluminal angioplasty, coronary artery

transluminal angioplasty, intracranial

treatment of neurologic disorder

treatment resistant

tremor

tricyclic antidepressant

trigeminovascular system

triptans

troponin T

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

ultrasonography

ultrasonography, carotid artery

upadacitinib

urinary tract infection

urticaria

uveitis

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

vascular endothelial growth factor

vasculitides

vasculopathy

ventricular assist device

verapamil

vertebral artery

vertebral artery disease

vertebral artery occlusion

vertebral-basilar artery, intraluminal clot

vertebral-basilar insufficiency

vertebrobasilar artery thickening

vertebrobasilar, artery stenosis

vibratory sensation, abnormal

viral infection

viral infection, CNS

viral infection, reactivation

visual acuity, decreased

visual acuity, decreased, monocular

visual field defect

visual impairment

visual loss

visual loss, slow-unilateral

vitamin deficiency

vocal cord paralysis

vomiting, intractable

Waldenstrom's macroglobulinemia

walking, difficulty with

water channel antibodies

weakness

weakness, acute

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter disease, subcortical

Showing articles 200 to 250 of 331 << Previous Next >>

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy
JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009

A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
Mod Rheumatol 18:399-402, Kameda, T.,et al, 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008

Stem Cell Transplantation in a Patient With Late-Onset Nemaline Myopathy and Gammopathy
Neurol 71:531-532, Benveniste,O.,et al., 2008

Sporadic Late-Onset Nemaline Myopathy Effectively Treated by Melphalan and Stem Cell Transplant
Neurol 71:532-534,472, Voermans,N.C.,et al., 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Treating Patients with Wake-Up Stroke: The Experience of the AbESTT-II Trial
Stroke 39:3277-3282, Adams,H.P.,et al, 2008

Neurologic Improvement After Peripheral Blood Stem Cell Transplantation in POEMS Syndrome
Neurol 71:1691-1695, Kuwabara,S.,et al, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Intermittent Cyclophosphamide With Prednisone Versus Placebo for Polyneuropathy With IgM Monoclonal Gammopathy
Neurol 69:50-59, Niermeijer,J.M.F.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
Emerg Infect Dis 13:469-471, Meersseman, W.,et al, 2007

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006

Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006

Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006

Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005

Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Showing articles 200 to 250 of 331 << Previous Next >>